How WHO Solidarity Plus trial participants in countries on four continents are informed in writing
Journal of Global Health · 20.01.2023 · 13
DOI: 10.7189/jogh.13.04012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Health, online erschienen am 20.01.2023. Verfasst von Rafael Dal-Ré und 2 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Comprehension, Consent Forms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
It is unknown if changes have been made to the original participant's information sheet/informed consent form (PIS/ICF) provided by the WHO Solidarity Plus team when it was transferred to participating countries.
Methods
National principal investigators from 30 countries were asked if the original PIS/ICF was edited in their countries and, if so, to share with us the one used to recruit participants. We assessed whether the 25 different elements of information from the good clinical practice guidelines and the Declaration of Helsinki were present in, deficiently described, or absent from the PIS/ICFs.
Results
Nineteen national principal investigators responded: eight (Argentina, Brazil, Ethiopia, Georgia, Iran, Lebanon, Lithuania, and Malaysia) stated that no edits were introduced to the original PIS/ICF; eight (Canada, Colombia, Philippines, India, Ireland, Pakistan, Portugal, and Switzerland) added some elements of information in the national PIS/ICF; and three (Italy, Peru, and Spain) reported not participating in the trial. None of the elements included in the original PIS/ICF were omitted from the edited PIS/IFC. Six elements of information were omitted and five deficiently described in the original PIS/ICF. The number of elements omitted from the edited PIS/ICFs varied (range = 2-5). Nine PIS/ICFs incompletely described or omitted the informing of study participants about the study results, while five deficiently described or omitted the anticipated expenses for trial participation. Information concerning whom to contact for more information or in case of injury was deficient in six PIS/ICFs. Unlike the original PIS/ICF, all edited PIS/ICFs informed participants about the existence of compensation or treatment for any injury related to the trial.
Conclusions
WHO should consider adding three of the omitted elements in PIS/ICFs of future multinational similar trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.
- Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- Centre for Social Ethics and Policy, Department of Law, School of Social Sciences, University of Manchester, UK.
Zitieren
APA
Dal-Ré, R., Voo, T. C., & Holm, S. (2023). How WHO Solidarity Plus trial participants in countries on four continents are informed in writing. Journal of Global Health, 13. https://doi.org/10.7189/jogh.13.04012
Vancouver
Dal-Ré R, Voo TC, Holm S. How WHO Solidarity Plus trial participants in countries on four continents are informed in writing. Journal of Global Health. 2023;13. doi:10.7189/jogh.13.04012
BibTeX
@article{DalR2023,
author = {Dal-Ré, Rafael and Voo, Teck Chuan and Holm, Søren},
title = {How WHO Solidarity Plus trial participants in countries on four continents are informed in writing},
journal = {Journal of Global Health},
year = {2023},
volume = {13},
doi = {10.7189/jogh.13.04012}
}
EUVIMED